Improvement in PET myocardial perfusion image quality and quantification with flurpiridaz F 18

Journal of Nuclear Cardiology

Volumn 19, Issue SUPPL. 1, 2012, Pages

  Berman, Daniel S ^a   Germano, Guido ^a   Slomka, Piotr J ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLURPIRIDAZ F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RUBIDIUM 82; DIAGNOSTIC AGENT; PYRIDAZINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ANGIOCARDIOGRAPHY; AUTOMATION; CARDIAC GATED IMAGING; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CORONARY FLOW RESERVE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; HEART FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HUMAN; IMAGE DISPLAY; IMAGE PROCESSING; IMAGE QUALITY; IMAGE RECONSTRUCTION; IMAGING SYSTEM; INTERMETHOD COMPARISON; ISOTOPE LABELING; MEDICAL TECHNOLOGY; MOTION FROZEN IMAGING; MYOCARDIAL PERFUSION IMAGING; PATIENT MOBILITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE DIAGNOSIS; RADIATION ATTENUATION; RADIATION SCATTERING; RESPIRATORY GATED IMAGING; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CORONARY ARTERY DISEASE; IMAGE ENHANCEMENT; METHODOLOGY; SCINTISCANNING;

CORONARY ARTERY DISEASE; HUMANS; IMAGE ENHANCEMENT; MYOCARDIAL PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; PYRIDAZINES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84861498450     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-011-9487-4     Document Type: Review

References (15)

1. Nandalur KR, Dwamena BA, Choudri AF, Nandalur SR, Reddy P, Carlos RC. Diagnostic performance of positron emission tomography in the detection of coronary artery disease. Acad Radiol 2008;15:444-51.
2. Bateman TM, Heller GV, McGhie AI, Friedman JD, Case JA, Bryngelson JR, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: Comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol 2006;13:24-33.
3. Wells RG, de Kemp RA, Beanlands RSB. Positron emission tomography instrumentation. In: Heller GV, Mann A, Hendel R, editors. Nuclear cardiology. Technical applications. New York: McGrawHill; 2009. p. 25-48.
4. Huisman MC, Higuchi T, Reder S, Nekkola SG, Poethko T, Wester H-J, et al. Initial characterization of an 18F-labeled myocardial perfusion tracer. J Nucl Med 2008;49:630-6.
5. Nekolla SG, Reder S, Saraste A, Higuchi T, Dzewas A, Preissel M, et al. Evaluation of the novel myocardial perfusion positronemission tomography tracer 18F-BMS-747158-02: Comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation 2009;119:2333-42.
6. Port S. Imaging guidelines for nuclear cardiology procedures, part 2. J Nucl Cardiol 1999;6:G48-84.
7. Tamarappoo B, Nakazato R, Shmilovich H, Hayes S, Thomson L, Friedman J, et al. Comparison of myocardial stress perfusion defect assessment using 99mTc-sestamibi SPECT vs. BMS747158 PET. J Nucl Med 2010;51:153 [abstract].
8. Berman DS, Kang X, Gransar H, Gerlach J, Friedman LD, Hayes SW, et al. Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysis. J Nucl Cardiol 2009;16: 45-53.
9. Mahmarian JJ, Cerqueira MD, Iskandrian AE, Bateman TM, Thomas GS, Hendel RC, et al. Regadenoson induces comparable left ventricular perfusion defects as adenosine: A quantitative analysis from the ADVANCE MPI 2 trial. J Am Coll Cardiol Imaging 2009;2:959-68.
10. Slomka PJ, Maddahi J, Le Meunier L, Lazewatsky JL, Germano G, Berman DS. Multicenter development of normal perfusion and function limits for stress and rest flurpiridaz F-18 cardiac PET. J Nucl Cardiol 2010;17:725 [abstract].
11. Panin VY, Kehren F, Michel C, Casey M. Fully 3-D PET reconstruction with system matrix derived from point source measurements. IEEE Trans Med Imag. 2006;25(7):907-21. doi:10.1109/TMI.2006.876171.
12. LeMeunier L, Slomka PJ, Dey D, Ramesh A, Thomson LEJ, Hayes SW, et al. Enhanced definition PET for cardiac imaging. J Nucl Cardiol 2010;17:414-26.
13. Slomka PJ, Nishina H, Berman DS, Kang X, Akincioglu C, Friedman JD, et al. "Motion-frozen" display and quantification of myocardial perfusion. J Nucl Med 2004;45:1128-34.
14. Woo J, Tamarappoo B, Dey D, Nakazato R, Le Meunier L, Ramesh A, et al. Automatic 3D registration of dynamic stress and rest (82)Rb and flurpiridaz F 18 myocardial perfusion PET data for patient motion detection and correction. Med Phys. 2011;38: 6313-26.
15. Le Meunier L, Slomka PJ, Ramesh A, Thomson L, Hayes S, Tamarappoo BK, Cheng V, Lezewatsky J, Germano G, Berman DS. Enhanced dual gated cardiac perfusion PET using a new F-18 imaging agent (BMS747158). J Nucl Med. 2010;51(Supp 2):522.